These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 17605973)
21. [Distribution of lipoprotein associated phospholipase A2 in Czech population and its interaction with conventional cardiovascular risk]. Mayer O; Seidlerová J; Wohlfart P; Trefil L; Bruthans J; Filipovský J; Cífková R Vnitr Lek; 2013 May; 59(5):344-51. PubMed ID: 23767446 [TBL] [Abstract][Full Text] [Related]
22. [Relationship between concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of the arterial wall in patients with low and moderate risk by SCORE scale]. Urazalina SZh; Titov VN; Vlasik TN; Balakhonova TV; Karpov IuA; Kukharchuk VV; Boĭtsov SA Ter Arkh; 2011; 83(9):29-35. PubMed ID: 22145385 [TBL] [Abstract][Full Text] [Related]
23. Increased plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to good collateral development in patients with isolated left coronary artery disease. Orem C; Kahraman N; Orem A; Uçar U; Yucesan FB; Mentese A Int J Cardiol; 2011 Apr; 148(1):117-9. PubMed ID: 21316774 [No Abstract] [Full Text] [Related]
24. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up. Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783 [TBL] [Abstract][Full Text] [Related]
25. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182 [TBL] [Abstract][Full Text] [Related]
26. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study. Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676 [TBL] [Abstract][Full Text] [Related]
27. Phospholipase A2 enzymes and the risk of atherosclerosis. Rosenson RS; Hurt-Camejo E Eur Heart J; 2012 Dec; 33(23):2899-909. PubMed ID: 22802388 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Esenwa CC; Elkind MS Nat Rev Neurol; 2016 Oct; 12(10):594-604. PubMed ID: 27615422 [TBL] [Abstract][Full Text] [Related]
35. The emerging role of lipoprotein-associated phospholipase A2 in cerebrovascular disease. Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):160. PubMed ID: 22119229 [No Abstract] [Full Text] [Related]
36. Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe? Heistad D; Doshi H JACC Cardiovasc Imaging; 2015 Jan; 8(1):34-36. PubMed ID: 25592694 [No Abstract] [Full Text] [Related]